Safety Alerts

MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd)

Published
Source
PSNC Dispensing & Supply News
Imported
12 Nov 2026

MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd) Drug alert number: EL(26)A/48 Date issued: 12 November 2026 Star Pharmaceuticals Limited have informed the MHRA of a typographical error on the strength of hydrochlorothiazide printed on the front face of the carton which incorrectly states “12. mg” instead of [...]

The post MHRA Class 4 Medicines Defect Notification: Enalapril maleate/ Hydrochlorothiazide 20 mg/12.5 mg Tablets (Star Pharmaceuticals Ltd) appeared first on Community Pharmacy England.

View original alert (opens in a new tab)

Important: This alert is gathered automatically for information only. Always refer to the original source and follow your practice’s own clinical governance procedures.

The weekly digest lists every alert published in a week, grouped by source. View the weekly digest

Back to Safety Alerts